Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2196/20904
PubMed Identifier: 33211022
Publication URI: http://europepmc.org/abstract/MED/33211022
Type: Journal Article/Review
Volume: 9
Parent Publication: JMIR research protocols
Issue: 11
ISSN: 1929-0748